Stemcell Holdings Stock Net Income
| STMM Stock | USD 0.06 0.00 0.00% |
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Stemcell Holdings, as well as the relationship between them.
Stemcell Holdings' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Stemcell Holdings' valuation are provided below:Stemcell Holdings does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Stemcell |
Stemcell Holdings 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Stemcell Holdings' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Stemcell Holdings.
| 10/28/2025 |
| 01/26/2026 |
If you would invest 0.00 in Stemcell Holdings on October 28, 2025 and sell it all today you would earn a total of 0.00 from holding Stemcell Holdings or generate 0.0% return on investment in Stemcell Holdings over 90 days. Stemcell Holdings is related to or competes with Medigene, and Vaccinex. More
Stemcell Holdings Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Stemcell Holdings' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Stemcell Holdings upside and downside potential and time the market with a certain degree of confidence.
Stemcell Holdings Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stemcell Holdings' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Stemcell Holdings' standard deviation. In reality, there are many statistical measures that can use Stemcell Holdings historical prices to predict the future Stemcell Holdings' volatility.Stemcell Holdings Backtested Returns
We have found three technical indicators for Stemcell Holdings, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Stemcell Holdings are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
Stemcell Holdings has no correlation between past and present. Overlapping area represents the amount of predictability between Stemcell Holdings time series from 28th of October 2025 to 12th of December 2025 and 12th of December 2025 to 26th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Stemcell Holdings price movement. The serial correlation of 0.0 indicates that just 0.0% of current Stemcell Holdings price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Stemcell Holdings reported net income of 2.41 M. This is 99.29% lower than that of the Healthcare sector and 96.56% lower than that of the Biotechnology industry. The net income for all United States stocks is 99.58% higher than that of the company.
Stemcell Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Stemcell Holdings' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Stemcell Holdings could also be used in its relative valuation, which is a method of valuing Stemcell Holdings by comparing valuation metrics of similar companies.Stemcell Holdings is currently under evaluation in net income category among its peers.
Stemcell Fundamentals
| Return On Equity | 0.68 | |||
| Return On Asset | 0.34 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.48 % | |||
| Current Valuation | (3.47 M) | |||
| Shares Outstanding | 27.38 M | |||
| Shares Owned By Insiders | 85.22 % | |||
| Price To Book | 0.27 X | |||
| Price To Sales | 0.16 X | |||
| Revenue | 6.18 M | |||
| Gross Profit | 4.99 M | |||
| EBITDA | 3.73 M | |||
| Net Income | 2.41 M | |||
| Book Value Per Share | 0.22 X | |||
| Cash Flow From Operations | 2.52 M | |||
| Earnings Per Share | 0.11 X | |||
| Number Of Employees | 28 | |||
| Market Capitalization | 1.64 M | |||
| Total Asset | 6.42 M | |||
| Net Asset | 6.42 M |
About Stemcell Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Stemcell Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Stemcell Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Stemcell Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetOther Information on Investing in Stemcell Pink Sheet
Stemcell Holdings financial ratios help investors to determine whether Stemcell Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemcell with respect to the benefits of owning Stemcell Holdings security.